Dare Bioscience, Inc. (DARE) Financials

DARE Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 25.1 million 27.3 million
2023-06-30 23.2 million 25.9 million
2023-03-31 30.4 million 25.4 million
2022-12-31 43.8 million 32.7 million

DARE Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -8.0 million 636086
2023-06-30 -6.6 million 650186
2023-03-31 -16.1 million 624621
2022-12-31 -5.9 million 532133

DARE Net Income

No data available :(

DARE Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 13.9 million - 194586
2023-06-30 13.3 million - 295151
2023-03-31 19.8 million - 392892
2022-12-31 34.7 million - 488737

DARE Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 91.1 million
2023-06-30 86.4 million
2023-03-31 85.5 million
2022-12-31 84.6 million

DARE Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 22099 6.7 million 2.7 million -
2023-06-30 - 6.0 million 2.9 million -
2023-03-31 - 5.0 million 3.4 million -
2022-12-31 2697 13.0 million 3.2 million -

DARE Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 1.0 million 9260
2023-06-30 - 9615
2023-03-31 - 3602
2022-12-31 10.0 billion 4717

DARE

Price: $0.31

52 week price:
0.27
1.10

Earnings Per Share: -0.35 USD

P/E Ratio: -0.74

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 165200

Ebitda: -1.3 million

Market Capitalization: 48.3 million

Links: